Pramod Sachdeva

Pramod Sachdeva is the Founder and Managing Director at Princeton Blue. With over 40 years of experience in business and technology consulting, including 18 years working with Appian, Pramod has helped Life Sciences organizations modernize complex Clinical and Regulatory functions through AI, connected data, and process automation. He brings deep experience in applying technology to real-world business challenges and helping organizations connect their data, processes, and systems to create more efficient and transparent ways of working. Through his work at Princeton Blue, Pramod continues to explore how AI and process transformation can help Life Sciences organizations solve complex challenges and bring therapies to market faster.

AI in Life Sciences Transforming Clinical and Regulatory Workflows Blog Feature

AI in Life Sciences: Transforming Clinical and Regulatory Workflows

Pharma and biotech leaders today are under immense pressure. You’re asked to accelerate trial timelines, cut costs, and stay compliant with constantly evolving regulations; all while bringing innovative therapies to market faster. Manual processes and siloed systems make these goals harder to achieve. That’s where Artificial Intelligence (AI) is changing the game. AI is no

AI in Life Sciences: Transforming Clinical and Regulatory Workflows Read more

Shortcast 9 Smarter Site Selection with Process Automation Feature

Shortcast Episode 9: Smarter Site Selection with Process Automation

Selecting the right sites is one of the most critical and challenging steps in clinical trials. Yet, many sponsor organizations still rely on outdated processes, siloed data, and manual workflows that slow everything down and increase risk. In this shortcast, Pramod Sachdeva, Founder and Managing Director of Princeton Blue, explores how process automation is helping

Shortcast Episode 9: Smarter Site Selection with Process Automation Read more

Shortcast 8 How are leading pharma companies modernizing their labs Feature

Shortcast Episode 8: How are leading pharma companies modernizing their labs?

Pharma labs are under constant pressure to do more—faster. But with rising sample volumes, complex experiments, and rigid Laboratory Information Management Systems (LIMS), many labs are struggling to keep pace. While LIMS have served as the backbone of lab operations for years, they often create bottlenecks with their rigid workflows and siloed data. Labs are

Shortcast Episode 8: How are leading pharma companies modernizing their labs? Read more

Shortcast 7 Simplifying Global Label Management Feature

Shortcast Episode 7: Simplifying Global Label Management

How do global pharma companies ensure every product label remains accurate, compliant, and up to date across dozens of markets? Behind the scenes, label management is one of the most complex operational challenges in the pharmaceutical industry. Each country has its own regulatory authorities, workflows, and submission requirements, creating a maze of processes that can

Shortcast Episode 7: Simplifying Global Label Management Read more

Bridging the Legacy Gap How Data Fabric Powers Life Sciences Integration Blog Feature

Bridging the Legacy Gap: How Data Fabric Powers Life Sciences Integration

Key Topics Covered: The Legacy System Dilemma in Life Sciences What is Data Fabric? And Why It Matters? Life Sciences Use Cases for Data Fabric Benefits of Data Fabric in Life Sciences The Role of an Expert Partner Case Example: Faster Trial Reporting Through Unified Data Access Future Trends: AI-Enhanced and Cloud-Native Data Fabrics Data

Bridging the Legacy Gap: How Data Fabric Powers Life Sciences Integration Read more

Shortcast 6 What is Low code Process Automation Feature

Shortcast Episode 6: What is Low-code Process Automation?

As the pace of drug discovery accelerates, the organizations that thrive will be those that can adapt quickly. Traditional, siloed systems often make it difficult to respond to changing market conditions or evolving regulatory requirements. That’s why Low-code Process Automation is gaining momentum across the life sciences industry. In this shortcast, Pramod Sachdeva, Founder &

Shortcast Episode 6: What is Low-code Process Automation? Read more

How Unifying your Data can Drive Better Study and Site Feasibility Decisions Blog Feature

Smarter Site Selection in Clinical Trials: where Process Automation meets AI

A New Era for Feasibility in Clinical Research In the high-stakes world of pharma R&D, selecting the right clinical trial sites is both critical and complex. The stakes are high: the right site can fast-track study enrollment, while the wrong one can derail timelines and inflate costs. Yet, feasibility assessments and site selection are still

Smarter Site Selection in Clinical Trials: where Process Automation meets AI Read more

Shortcast 4 Navigating EU CTR Compliance with Workflow Automation Feature

Shortcast Episode 4: Navigating EU-CTR Compliance with Workflow Automation

  The European Union Clinical Trial Regulation (EU-CTR) was designed to bring consistency and transparency to how trials are assessed across Europe. For sponsors, however, keeping pace with these new requirements can feel overwhelming, especially when relying on outdated, manual processes. In this shortcast, Pramod Sachdeva explores why EU-CTR compliance is more than just a

Shortcast Episode 4: Navigating EU-CTR Compliance with Workflow Automation Read more

regulatory submissions process min

Smarter Regulatory Submissions, powered by Process Automation and AI

Life Sciences is one of the most highly regulated industries, given its impact on human health. Organizations must comply with complex regulations throughout the lifecycle of a drug – from development to approval and from manufacturing to safety. At the heart of this lies the regulatory submissions process, a critical function that ensures the safety,

Smarter Regulatory Submissions, powered by Process Automation and AI Read more

Scroll to Top